In today’s shifting financial waters, knowing what investors are actually funding can make all the difference. This practical panel brings together voices from across the funding landscape—including angels, venture capitalists, and corporate VCs—to discuss what milestones matter most and what they’re backing right now in medtech. Learn how to position your company for success at each inflection point, understand investor expectations, and gain real-world insight into funding trends that can help you catch the next rising tide.

Speakers:

• Paul Grand, MedTech Innovator (Moderator)
• Doug Kelly, ex-FDA
• Chris Neil, MTAF, Life Science Angels
• Biren Mehta, Johnson & Johnson